World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 95 9877 9267 386 374 433 49207

Emiel J. Th. Rutgers publications per year

The chart shows the history of publications by Emiel J. Th. Rutgers between 1991 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Emiel J. Th. Rutgers published across 35 years, from 1991 to 2025, averaging 14.5 papers a year. Output peaked at 57 publications in 2023. 10 of the 508 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1991 to 2025. Vertical axis: number of publications, 0 to 57. Peak 57 publications in 2023. 1991: 2 publications 1992: 2 publications 1993: 2 publications 1994: 2 publications 1995: 8 publications 1996: 8 publications 1997: 6 publications 1998: 8 publications 1999: 5 publications 2000: 7 publications 2001: 15 publications 2002: 10 publications 2003: 9 publications 2004: 19 publications 2005: 7 publications 2006: 20 publications 2007: 11 publications 2008: 16 publications 2009: 25 publications 2010: 27 publications 2011: 11 publications 2012: 40 publications 2013: 23 publications 2014: 21 publications 2015: 28 publications 2016: 22 publications 2017: 26 publications 2018: 16 publications 2019: 11 publications 2020: 15 publications 2021: 10 publications 2022: 9 publications 2023: 57 publications 2024: 6 publications 2025: 4 publications
1991 2025

508 publications in total across all disciplines

View publications per year as a table
Emiel J. Th. Rutgers: publications per year, 1991 to 2025
Year Publications
1991 2
1992 2
1993 2
1994 2
1995 8
1996 8
1997 6
1998 8
1999 5
2000 7
2001 15
2002 10
2003 9
2004 19
2005 7
2006 20
2007 11
2008 16
2009 25
2010 27
2011 11
2012 40
2013 23
2014 21
2015 28
2016 22
2017 26
2018 16
2019 11
2020 15
2021 10
2022 9
2023 57
2024 6
2025 4
Total 508
Download as CSV

Emiel J. Th. Rutgers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Emiel J. Th. Rutgers sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 421–440 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 433 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806 433
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Emiel J. Th. Rutgers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Emiel J. Th. Rutgers sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808 95
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Emiel J. Th. Rutgers is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with focused contributions in Cancer Research and Oncology. The scientist's work also intersects with Pulmonary and Respiratory Medicine, Genetics, and Molecular Biology as subfields of interest.

The main topics covered in their research include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Breast Lesions and Carcinomas
  • HER2/EGFR in Cancer Research
  • Breast Implant and Reconstruction

Emiel J. Th. Rutgers has frequently collaborated with several co-authors including Fátima Cardoso, Coralie Poncet, Martine Piccart, Laura van 't Veer, and Suzette Delaloge. This collaborative work has been published across multiple renowned venues. Among the most frequent publication venues are Cancer Research, Journal of Clinical Oncology, European Journal of Cancer, European Journal of Surgical Oncology, and The Breast.

The following selected recent papers reflect the scope and nature of their research:

  • "Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021," published in 2021 in Annals of Oncology
  • "70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age," published in 2021 in The Lancet Oncology
  • "Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials," published in 2021 in The Lancet Oncology
  • "Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial," published in 2022 in Journal of Clinical Oncology
  • "Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023," published in 2023 in Annals of Oncology

Best Publications

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

    Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard

  • Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

    Mila Donker;Geertjan van Tienhoven;Marieke E Straver;Philip Meijnen

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

    Saskia Litière;Gustavo Werutsky;Ian S Fentiman;Emiel Rutgers

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer

    Maaike de Boer;Carolien H.M. van Deurzen;Jos A.A.M. van Dijck;George F. Borm

  • Clinical application of the 70-gene profile: the MINDACT trial.

    Fatima Cardoso;Laura Van't Veer;Emiel Rutgers;Sherene Loi

  • Genome-wide association studies identify four ER negative-specific breast cancer risk loci

    Montserrat Garcia-Closas;Fergus J. Couch;Sara Lindstrom;Kyriaki Michailidou

  • Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

    Mila Donker;Saskia Litière;Gustavo Werutsky;Jean Pierre Julien

  • Lymphatic drainage patterns from the breast.

    Susanne H. Estourgie;Omgo E. Nieweg;Renato A. Valdés Olmos;Emiel J. Th. Rutgers

  • Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.

    Mila Donker;Marieke E. Straver;Jelle Wesseling;Claudette E. Loo

  • Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study

    Lotte E. Elshof;Konstantinos Tryfonidis;Leen Slaets;A. Elise van Leeuwen-Stok

  • The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

    Stella Mook;Marjanka K. Schmidt;Giuseppe Viale;Giuseppe Viale;Giancarlo Pruneri;Giancarlo Pruneri

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

Frequent Co-Authors

Jelle Wesseling
Jelle Wesseling Leiden University Medical Center
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Fatima Cardoso
Fatima Cardoso Champalimaud Foundation
Omgo E. Nieweg
Omgo E. Nieweg Royal Prince Alfred Hospital
Marjanka K. Schmidt
Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital
Giuseppe Viale
Giuseppe Viale University of Milan
Sjoerd Rodenhuis
Sjoerd Rodenhuis Antoni van Leeuwenhoek Hospital
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative routes in healthcare is increasingly popular for those looking to fast-track their careers in medicine or related fields. Many students consider online direct entry msn programs for non-nurses as a pathway to advanced nursing roles, even for those without a traditional nursing background.

Admission requirements can be a barrier for some, but options like the easiest rn program to get into help open doors for aspiring nurses who may not have top academic scores or healthcare experience.

For those interested in administrative healthcare roles, options such as online medical coding classes with financial aid offer flexibility and support while preparing graduates for in-demand positions.

Some programs are also minimizing standardized test barriers. For example, lpn to rn programs without teas test provide a seamless path for licensed practical nurses to advance their credentials.

With so many accessible online programs, students can find a career pathway that matches their interests and needs—often with greater flexibility, reduced prerequisites, and support options like financial aid.

Best Scientists Citing Emiel J. Th. Rutgers

Trending Scientists

Recently Published Articles